Private Advisor Group, LLC Clearside Biomedical, Inc. Transaction History

Private Advisor Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$1.3 - $2.49 $9,100 - $17,430	-7,000 Reduced 31.96%	14,900 $22,000
Q1 2022 May 12, 2022	SELL	$1.35 - $2.88 $1,485 - $3,168	-1,100 Reduced 4.78%	21,900 $50,000
Q3 2021 Oct 14, 2021	SELL	$4.83 - $7.2 $2,415 - $3,600	-500 Reduced 2.13%	23,000 $138,000
Q2 2021 Aug 12, 2021	SELL	$2.32 - $5.38 $3,479 - $8,070	-1,500 Reduced 6.0%	23,500 $114,000
Q1 2021 Apr 22, 2021	BUY	$2.24 - $4.25 $56,000 - $106,250	25,000 New	25,000 $62,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.